化合物 RS 504393【300816-15-3】产品图
文献支持

化合物 RS 504393【300816-15-3】

收藏
  • ¥228 - 4304
  • TargetMol
  • T5384
  • 2026年07月07日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • CAS号

      300816-15-3

    • 规格

      1mg/1mLx10mM(inDMSO)/5mg/10mg/25mg/50mg/100mg

    规格:1mg产品价格:¥228.0
    规格:1mLx10mM(inDMSO)产品价格:¥591.0
    规格:5mg产品价格:¥537.0
    规格:10mg产品价格:¥976.0
    规格:25mg产品价格:¥2136.0
    规格:50mg产品价格:¥3136.0
    规格:100mg产品价格:¥4304.0

    Product Introduction

    Bioactivity

    名称 RS 504393
    描述 RS 504393 is a highly selective CCR2 chemokine receptor antagonist (IC50s: 89 nM and > 100 μM for human recombinant CCR2 and CCR1).
    细胞实验 Briefly, cytosolic calcium influx was measured in CCR2-CHL cells loaded with the fluorescent dye Fura-2-AM. Quantitation of signal intensity used the integrated signal intensity for 82 s after the addition of chemokine and thus has units of M·s. Antagonism by various compounds of calcium influx was measured using an approximate ED50 dose of MCP-1 (3 nM) and an approximate ED25 dose for MCP-3 (5 nM). Chemotaxis was measured over 1 h using THP-1–5X cells in a 96-well Boyden chamber apparatus. Cell migration through the polycarbonate filter was quantified by fluorescent staining using propidium iodide in 0.1% Triton X-100. These assays typically gave stimulated to unstimulated migration of 6-fold, range 4–10-fold, using a maximally effective concentration of MCP-1. Chemotaxis antagonist measurements used 3 nM MCP-1 or RANTES; these concentrations are near the ED95 attractant concentration for MCP-1 and for RANTES as agonists. The data are expressed by normalization to the uninhibited migration caused by the agonist chemokine. The antagonist was present in both chambers of the Boyden apparatus [1].
    激酶实验 Briefly, binding was measured using membranes prepared from two cell lines, THP-1 and CCR2-CHL cells. Each competition assay was composed of cell membranes, 50 pM 125I-MCP, MCP buffer, protease inhibitors, and test compound. Equilibrium was achieved by incubation at 28?°C for 90 min. Membrane-bound 125I-MCP was collected by filtration through GF/B filters presoaked in polyethyleneimine and bovine serum albumin, followed by four rapid washes with approximately 0.5 ml of ice-cold buffer containing 0.5 M NaCl and 10 mM HEPES, pH 7.4. MCP buffer consists of 50 mMHEPES, pH 7.2, 1 mM CaCl2, 5 mMMgCl2, and 0.1% bovine serum albumin. Protease inhibitors include 0.1 mM phenylmethylsulfonyl fluoride, 1 μM leupeptin, and 0.35 mg/ml pepstatin. THP-1 cells are a human monocyte cell line that express both CCR1 and CCR2. CCR2-CHL cells are Chinese hamster lung cells that have been stably transformed with an expression vector bearing the human CCR2b receptor [1].
    动物实验 To evaluate the therapeutic effects of MCP-1/CCR2 signaling, either propagermanium (3 or 8 mg/kg orally once a day) or RS-504393 (2 mg/kg orally twice a day) was mandatorily injected into their mouths to wild-type mice from 3 days before ureteral ligation until the day of sacrifice. In addition, to determine the viability for the usage of CCR2 antagonists for the treatment of renal fibrosis, propagermanium (8 mg/kg) was given daily, beginning 4 days after ureter ligation. For pathological examination, both the obstructed and contralateral kidneys were harvested from UUO animals 4, 7, and 14 days after ureteral ligation (n = 5 at each time point). Untreated age-matched male wild-type mice and CCR2-deficient mice were used as normal control (n = 6 for each group). Since propagermanium treatment was started from 3 days before ureteral ligation, mice treated with propagermanium for 3 days at day 0 were used as a negative control (n = 5) [3].
    体外活性 RS-504393抑制了CCR2-CHL细胞中由MCP-1刺激的钙流入,其IC50值为35 nM [1]。作为CCR2的拮抗剂,RS 504393的处理显著抑制了过敏原诱导的β-己糖苷酶释放。这种抑制效果可通过补充重组MCP-1蛋白(100 pg/mL)[2]部分逆转。
    体内活性 相较于接受了载体处理的小鼠明显展现出急性炎症迹象,RS 504393处理的小鼠却未表现出即时过敏的临床迹象。在天真(naive)动物中未观察到任何效果。RS 504393处理的小鼠中肥大细胞的脱颗粒作用显著受到抑制,但对天真小鼠无影响[2]。与CCR2缺陷小鼠所获得的结果类似,RS-504393的治疗显著减轻了肾脏病理变化,特别是通过减少I型胶原蛋白合成介导的广泛间质纤维化[3]。
    存储条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
    溶解度 DMSO : 10 mg/mL (23.95 mM), Sonication is recommended.
    H2O : Insoluble
    10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (2.4 mM), Sonication is recommended.
    关键字 RS-504393 | RS504393 | RS 504393 | Inhibitor | inhibit | CCR2 | CCR | CC chemokine receptor
    相关产品 BMS-817399 | Maraviroc | Pirfenidone | Ancriviroc | AZD2098 | Vercirnon | PNU-177864 | CCR2 antagonist 5 | Artemotil | MLN-3897 TFA | INCB-9471 | CCR6 antagonist 1
    相关库 Inhibitor Library | Immuno-Oncology Compound Library | Bioactive Compound Library | Bioactive Compounds Library Max | Cytokine Inhibitor Library | Highly Selective Inhibitor Library | NO PAINS Compound Library | Nonsteroidal Anti-Inflammatory Compound Library | GPCR Compound Library | Membrane Protein-targeted Compound Library | Immunology/Inflammation Compound Library | Target-Focused Phenotypic Screening Library

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    官网有文献
    相关实验
    • 一种新型手性毛细管柱的研制及其性能

      毛细管柱对所选择的手性化合物具有手性识别性,尤其对烯烃,酮类,酯类等对映体具有很强的拆分能力。由于 β-环糊精聚合物保留了β-环糊精的腔体结构,没有引入大的空间位阻,偶极-偶极作用和氢键作用仍然存在,空穴内包结作用依然能够进行,构象诱导易于进行。β-环糊精聚合物固定相对极性、非极性及易形成氢键的手性化合物具有较好的拆分能力。 表1 几类手性化合物的拆分结果 Tab.1 Separation of some isomers   对映体 柱温(℃) R1 α RS  α-蒎烯 90 

    • CD15/CD15s/CD15u分子

      CD15/CD15s/CD15u 分子   CD15 常用单克隆抗体或代号: MY1,LeuM1 主要表达细胞: G,(M),RS [AS] 分子质量(kDa)和结构: Lewisx3FAL,X- hapten 功    能: 参与中性粒细胞粘附和吞噬   CD15s 常用单克隆抗体或代号: (唾液酸化CDl5) 主要表达细胞: G,M [AS] 分子质量(kDa)和结构: Sialyl

    • 曾经帮人度饥荒,如今让你囤脂肪!王立峰等 Cell 报道这个远古 miRNA 为何让人「难瘦」

      远古时期,我们的祖先的生活并不像现在这么富足。无法获得稳定食物来源,使得对碳水化合物,脂肪以及盐的渴望被刻进了人类的基因之中。这些基因也成为了我们解决三高与肥胖问题路上最大的障碍。 图片来源:Cell 2020 年 10 月 14 号,来自麻省总医院的王立峰以及加州大学伯克利分校 Anders M. Näär 团队在顶级期刊 Cell 上刊登了题为 A MicroRNA Linking Human Positive Selection and Metabolic Disorders 的研究

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥992
    爱必信(上海)生物科技有限公司
    2026年05月27日询价
    ¥2875
    MedChemExpress LLC
    2025年12月05日询价
    ¥770
    北京沃比森科技有限公司
    2025年11月10日询价
    ¥265
    TargetMol中国
    2025年07月15日询价
    ¥220
    山东思科捷生物技术有限公司
    2026年06月02日询价
    文献支持
    化合物 RS 504393【300816-15-3】
    ¥228 - 4304